Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Megan Turner

Concepts (151)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hypoxia-Ischemia, Brain
2
2024
50
1.520
Why?
Acute Kidney Injury
3
2025
866
1.410
Why?
HIV Infections
20
2026
3215
1.310
Why?
Tuberculosis
3
2026
290
0.930
Why?
Hypothermia, Induced
2
2024
96
0.910
Why?
AIDS-Related Opportunistic Infections
1
2026
130
0.890
Why?
Anti-HIV Agents
6
2026
914
0.870
Why?
HIV-1
5
2026
913
0.850
Why?
Infant, Premature, Diseases
1
2025
113
0.820
Why?
Ductus Arteriosus, Patent
1
2023
49
0.740
Why?
Infant, Newborn, Diseases
1
2023
113
0.710
Why?
Viral Load
6
2026
526
0.450
Why?
CD4 Lymphocyte Count
4
2026
280
0.440
Why?
HIV Integrase Inhibitors
3
2021
80
0.420
Why?
Brain
2
2024
2991
0.420
Why?
Biomarkers
2
2024
4340
0.370
Why?
Infant, Newborn
4
2025
6460
0.360
Why?
Antitubercular Agents
2
2024
212
0.340
Why?
Magnetic Resonance Imaging
1
2024
3926
0.330
Why?
Brazil
3
2026
179
0.330
Why?
CD4-CD8 Ratio
2
2019
23
0.270
Why?
Continuity of Patient Care
3
2018
298
0.250
Why?
Glucuronosyltransferase
1
2026
18
0.240
Why?
Proportional Hazards Models
3
2025
1331
0.230
Why?
Anti-Retroviral Agents
2
2018
250
0.220
Why?
Arylamine N-Acetyltransferase
1
2024
8
0.220
Why?
Infant, Extremely Premature
1
2025
67
0.220
Why?
Coinfection
1
2026
143
0.210
Why?
Erythropoietin
1
2025
100
0.210
Why?
Hepatitis A Virus Cellular Receptor 1
1
2024
42
0.200
Why?
Prospective Studies
3
2026
8123
0.200
Why?
Lipocalin-2
1
2024
80
0.200
Why?
Cardiovascular Diseases
3
2024
2219
0.200
Why?
Humans
27
2026
146342
0.190
Why?
HIV Seropositivity
1
2024
118
0.190
Why?
Indomethacin
1
2023
76
0.190
Why?
Multiple Organ Failure
1
2023
122
0.190
Why?
Interleukin-18
1
2024
234
0.180
Why?
Female
20
2026
79499
0.180
Why?
Male
18
2026
73396
0.180
Why?
Benzoxazines
2
2021
31
0.180
Why?
Gestational Age
1
2025
990
0.170
Why?
Adult
18
2026
41087
0.170
Why?
Bipolar Disorder
1
2024
285
0.170
Why?
Reverse Transcriptase Inhibitors
2
2020
89
0.170
Why?
Genotype
1
2026
1879
0.170
Why?
Creatinine
1
2023
511
0.170
Why?
Weight Gain
3
2021
562
0.160
Why?
Risk Factors
6
2025
10921
0.160
Why?
Healthcare Disparities
2
2025
733
0.160
Why?
Ischemia
1
2023
421
0.160
Why?
Multivariate Analysis
1
2024
1543
0.160
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2023
344
0.150
Why?
Noncommunicable Diseases
1
2020
21
0.150
Why?
Mood Disorders
1
2020
130
0.140
Why?
Retrospective Studies
10
2025
17438
0.140
Why?
Southeastern United States
3
2025
37
0.140
Why?
Infant, Premature
1
2023
622
0.140
Why?
Substance Abuse, Intravenous
1
2019
131
0.130
Why?
Hepatitis C, Chronic
1
2019
150
0.130
Why?
No-Show Patients
1
2017
3
0.130
Why?
Treatment Outcome
4
2026
11821
0.130
Why?
Liver Cirrhosis
1
2019
278
0.130
Why?
Body Mass Index
3
2025
2458
0.130
Why?
Diabetes Mellitus
1
2025
1101
0.120
Why?
Middle Aged
15
2025
36619
0.120
Why?
Health Literacy
1
2018
183
0.110
Why?
Cohort Studies
7
2024
6077
0.110
Why?
Stress Disorders, Post-Traumatic
1
2023
892
0.110
Why?
Kidney
1
2023
1498
0.110
Why?
Medroxyprogesterone Acetate
1
2015
33
0.110
Why?
Contraceptives, Oral, Hormonal
1
2015
30
0.110
Why?
Marijuana Abuse
1
2017
217
0.100
Why?
Ambulatory Care Facilities
3
2024
269
0.100
Why?
Contraceptive Agents, Female
1
2015
80
0.100
Why?
Medication Adherence
1
2018
535
0.100
Why?
Tennessee
3
2019
57
0.100
Why?
Marijuana Use
1
2017
218
0.100
Why?
Socioeconomic Factors
1
2018
1327
0.100
Why?
Patient Compliance
1
2017
589
0.090
Why?
Sexually Transmitted Diseases
1
2015
163
0.090
Why?
Liver Diseases
1
2016
304
0.090
Why?
Cannabis
1
2020
521
0.090
Why?
Lipopolysaccharide Receptors
1
2013
88
0.090
Why?
Neoplasms
2
2019
2954
0.090
Why?
Patient-Centered Care
1
2017
553
0.090
Why?
Kidney Diseases
1
2016
428
0.090
Why?
Pharmacogenetics
2
2024
176
0.090
Why?
Cyclopropanes
2
2021
83
0.080
Why?
Alkynes
2
2021
67
0.070
Why?
Interleukin-6
1
2013
784
0.070
Why?
Young Adult
6
2024
14330
0.070
Why?
Caribbean Region
1
2026
29
0.060
Why?
Central America
1
2026
28
0.060
Why?
South America
1
2026
56
0.060
Why?
Mental Disorders
1
2015
1148
0.060
Why?
Glutathione Transferase
1
2024
92
0.050
Why?
Affective Symptoms
1
2024
53
0.050
Why?
Adult Survivors of Child Abuse
1
2024
33
0.050
Why?
Tuberculosis, Pulmonary
1
2024
127
0.050
Why?
Incidence
2
2024
2936
0.050
Why?
Metabolic Diseases
1
2024
114
0.050
Why?
HIV
1
2024
249
0.050
Why?
United States
4
2023
16136
0.040
Why?
Academic Medical Centers
1
2025
561
0.040
Why?
Adolescent
4
2024
22557
0.040
Why?
Oxazines
1
2020
36
0.040
Why?
Heterocyclic Compounds, 3-Ring
1
2020
44
0.040
Why?
Age Factors
2
2018
3347
0.040
Why?
Lymphopenia
1
2019
62
0.040
Why?
Guinea Pigs
1
2019
159
0.040
Why?
Obesity
1
2013
3131
0.040
Why?
Antiretroviral Therapy, Highly Active
1
2020
278
0.030
Why?
Aged
4
2019
26432
0.030
Why?
Pyridones
1
2020
210
0.030
Why?
Piperazines
1
2020
368
0.030
Why?
Cause of Death
1
2019
456
0.030
Why?
Referral and Consultation
1
2023
881
0.030
Why?
Hepatitis C
1
2019
251
0.030
Why?
Kaplan-Meier Estimate
1
2019
970
0.030
Why?
Mass Screening
1
2025
1307
0.030
Why?
Polymorphism, Single Nucleotide
1
2024
2240
0.030
Why?
Appointments and Schedules
1
2017
97
0.030
Why?
Marijuana Smoking
1
2020
249
0.030
Why?
Social Class
1
2018
260
0.030
Why?
Models, Theoretical
1
2019
561
0.030
Why?
Self Report
1
2020
870
0.030
Why?
RNA, Viral
1
2019
693
0.030
Why?
Sexual and Gender Minorities
1
2019
269
0.030
Why?
Residence Characteristics
1
2018
385
0.030
Why?
Depression
1
2024
1575
0.030
Why?
Odds Ratio
1
2017
1077
0.030
Why?
Comorbidity
1
2019
1665
0.030
Why?
Poverty
1
2018
530
0.030
Why?
Antiviral Agents
1
2019
779
0.020
Why?
CD4-Positive T-Lymphocytes
1
2020
1150
0.020
Why?
RNA
1
2020
926
0.020
Why?
Chronic Disease
1
2019
1827
0.020
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2013
79
0.020
Why?
Chemokine CCL3
1
2013
26
0.020
Why?
Sexual Behavior
1
2017
490
0.020
Why?
Solubility
1
2013
240
0.020
Why?
Risk
1
2015
920
0.020
Why?
Ambulatory Care
1
2017
628
0.020
Why?
C-Reactive Protein
1
2013
429
0.020
Why?
Inflammation Mediators
1
2013
508
0.020
Why?
Longitudinal Studies
1
2017
3017
0.020
Why?
Obesity, Morbid
1
2013
287
0.020
Why?
Follow-Up Studies
1
2017
5439
0.020
Why?
Risk Assessment
1
2016
3712
0.010
Why?
Animals
1
2019
38107
0.010
Why?
Turner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)